Antiviral effects of Stichopus japonicus acid mucopolysaccharide on hepatitis B virus transgenic mice

  • Yongning Xin
  • , Wei Li
  • , Linlin Lu
  • , Li Zhou
  • , David W. Victor
  • , Shiying Xuan

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Hepatitis B virus (HBV) is a significant global pathogen and efficient cure for HBV patients is still a challenging goal. We previously reported that acidic mucopolysaccharide from stichopus japonicus selenka (SJAMP) could inhibit HBsAg and HBeAg expression in vitro. However, the potential anti-HBV effects of SJAMP in vivo have not yet been explored. In this study, we show that SJAMP exhibits potent anti-HBV activity in HBV transgenic mice in a dose-dependent manner. Specifically, sixty HBV transgenic male BALB/c mice were randomly selected to receive the treatment of PBS, low dose SJAMP (30 mg kg−1), middle dose SJAMP (40 mg kg−1), high dose SJAMP (50 mg kg−1) and IFN (45 IU kg−1) for 30 d. SJAMP treatment suppressed serum HBV-DNA, and liver HBsAg and HBcAg levels in HBV-transgenic mice. The present study highlights the potential application of SJAMP in HBV therapy.

Original languageEnglish
Pages (from-to)719-725
Number of pages7
JournalJournal of Ocean University of China
Volume15
Issue number4
DOIs
StatePublished - 1 Aug 2016
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Stichopus japonicus acid mucopolysaccharide
  • antiviral
  • hepatitis B virus
  • transgenic mice

Fingerprint

Dive into the research topics of 'Antiviral effects of Stichopus japonicus acid mucopolysaccharide on hepatitis B virus transgenic mice'. Together they form a unique fingerprint.

Cite this